Nov 20, 2024
Global Regulatory Strategy Webinar
Vivpro Corporation has partnered with experts and industry leaders to discuss critical pharma and biotech topics. Our goal is to share valuable information and allow the audience to engage with questions while they receive real-time feedback.
For our November session, we are joined by Meriem Gaval Cruz, Director, Global Regulatory Lead
At this WebChat you will gain insights into the following:
Strategies for Balancing Global Harmonization with Local Market Requirements
Role of Health Technology Assessments (HTA) in Global Registration
Preparing to Meet Regional Evidence Standards
Best Practices for Designing Multinational Phase 3 Clinical Trials
Ensuring Compliance with Global Data Requirements
About Meriem Gaval Cruz
Meriem Gaval Cruz, PhD, RAC (Drugs) is the Global Regulatory Lead at NovoNordisk with 15 years of experience in regulatory strategy and commercialization of small molecules and biologics. Previously at Biogen and regulatory consultancies, she has led US and EU regulatory applications. A neuroscientist by training, Meriem holds a PhD from Emory and has worked on pharmacotherapies for drug addiction and affective disorders. In her free time, she enjoys puzzles, podcasts, and family time.
